Investors & Media

Transformative science, targeted medicines

We are working to advance a deep pipeline of precision therapies, designed to allow patients to live longer, better lives. Our approach combines world-leading expertise in protein kinases with sound execution and an intense focus on discovery.

SEC Filings

SEC Filings

Search
Filing date Form Description View
3

Initial filing by director officer or owner of more than ten percent.

 View HTML
0001104659-15-031950.pdf
0001104659-15-031950.rtf
0001104659-15-031950.xls
3

Initial filing by director officer or owner of more than ten percent.

 View HTML
0001104659-15-031956.pdf
0001104659-15-031956.rtf
0001104659-15-031956.xls
3

Initial filing by director officer or owner of more than ten percent.

 View HTML
0001104659-15-031955.pdf
0001104659-15-031955.rtf
0001104659-15-031955.xls
3

Initial filing by director officer or owner of more than ten percent.

 View HTML
0001104659-15-031957.pdf
0001104659-15-031957.rtf
0001104659-15-031957.xls
3

Initial filing by director officer or owner of more than ten percent.

 View HTML
0001104659-15-031953.pdf
0001104659-15-031953.rtf
0001104659-15-031953.xls
3

Initial filing by director officer or owner of more than ten percent.

 View HTML
0001104659-15-031954.pdf
0001104659-15-031954.rtf
0001104659-15-031954.xls
3

Initial filing by director officer or owner of more than ten percent.

 View HTML
0001104659-15-031951.pdf
0001104659-15-031951.rtf
0001104659-15-031951.xls
3

Initial filing by director officer or owner of more than ten percent.

 View HTML
0001104659-15-031952.pdf
0001104659-15-031952.rtf
0001104659-15-031952.xls
424B4

Form of prospectus disclosing information facts events covered in both forms 424B1 424B3

 View HTML
0001047469-15-004205.pdf
0001047469-15-004205.rtf
0001047469-15-004205.xls
S-8

Securities offered to employees pursuant to employee benefit plans

 View HTML
0001104659-15-032381.pdf
0001104659-15-032381.rtf
0001104659-15-032381.xls